Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue
Michael A. Pfaller(University of Iowa), Maria M. Traczewski(Human BioMolecular Research Institute), Thomas R. Rogers(Scripps Research Institute), Robert Rennie(Alberta Hospital Edmonton), Jacques Billé(University Hospital of Lausanne), Jacques F. Meis(Radboud University Nijmegen), Michael G. Rinaldi(Murphy Oil Corporation (United States)), A L Barry(Pfizer (United Kingdom)), David Ellis(Women's and Children's Hospital), Steven D. Brown(AZ Technology (United States))
Cited by 14
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k